Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice

Fanming Kong1,2, Chaoran Wang1,2,3, Jing Zhang1,2

  • 1Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.

Chinese Herbal Medicines
|December 14, 2023
PubMed

Insights

Chinese herbal medicines (CHMs) show promise in treating prostate cancer by targeting multiple pathways. Research highlights their potential in inducing apoptosis and suppressing tumor growth with fewer side effects.

Area of Science:

  • Oncology
  • Pharmacology
  • Integrative Medicine

Background:

  • Prostate cancer is a significant global health concern, with precision medicine facing challenges like drug resistance and adverse effects.
  • Chinese herbal medicines (CHMs) offer a promising alternative cancer therapy due to their multi-target, multi-pathway, and low-toxicity profiles.

Purpose of the Study:

  • To review recent research on the efficacy and mechanisms of CHMs in treating prostate cancer.
  • To identify effective CHM formulas, extracts, and compounds for prostate cancer therapy.

Main Methods:

  • A systematic literature search was conducted across PubMed, Embase, and Web of Science for studies published in the last five years.
  • Included experimental and clinical research on CHMs for prostate cancer treatment.

Main Results:

  • Five CHM formulas, six single extracts, and 12 compounds demonstrated anti-cancer effects.
  • These agents induced apoptosis, autophagy, and cell cycle arrest, while suppressing angiogenesis, proliferation, and migration.
  • Mechanisms involved key signaling pathways like PI3K/Akt/mTOR, AR, EGFR, and Wnt/β-catenin.

Conclusions:

  • CHMs exhibit significant potential in managing both hormone-sensitive and castration-resistant prostate cancer.
  • CHMs offer a viable complementary approach, warranting further investigation for clinical application and experimental design.